These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28177533)

  • 1. Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy.
    Kan N; Silverman ED; Kingdom J; Dutil N; Laskin C; Jaeggi E
    Prenat Diagn; 2017 Apr; 37(4):375-382. PubMed ID: 28177533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal Anti-Ro Antibody Titers Obtained With Commercially Available Immunoassays Are Strongly Associated With Immune-Mediated Fetal Heart Disease.
    Jaeggi E; Kulasingam V; Chen J; Fan CS; Laskin C; Hamilton RM; Hiraki LT; Silverman ED; Sepiashvili L
    Arthritis Rheumatol; 2023 Sep; 75(9):1556-1565. PubMed ID: 36996277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis.
    Nield LE; Silverman ED; Taylor GP; Smallhorn JF; Mullen JB; Silverman NH; Finley JP; Law YM; Human DG; Seaward PG; Hamilton RM; Hornberger LK
    Circulation; 2002 Feb; 105(7):843-8. PubMed ID: 11854125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers.
    Kaizer AM; Lindblade C; Clancy R; Tebo AE; Drewes B; Masson M; Chang M; Fraser N; Buyon JP; Cuneo BF
    Am J Obstet Gynecol; 2022 Nov; 227(5):761.e1-761.e10. PubMed ID: 35690080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal echocardiographic assessment of endocardial fibroelastosis in maternal anti-SSA antibody-associated complete heart block.
    Aoki H; Inamura N; Kawazu Y; Nakayama M; Kayatani F
    Circ J; 2011; 75(5):1215-21. PubMed ID: 21436591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy.
    Trucco SM; Jaeggi E; Cuneo B; Moon-Grady AJ; Silverman E; Silverman N; Hornberger LK
    J Am Coll Cardiol; 2011 Feb; 57(6):715-23. PubMed ID: 21292131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies.
    Cuneo BF; Sonesson SE; Levasseur S; Moon-Grady AJ; Krishnan A; Donofrio MT; Raboisson MJ; Hornberger LK; Van Eerden P; Sinkovskaya E; Abuhamad A; Arya B; Szwast A; Gardiner H; Jacobs K; Freire G; Howley L; Lam A; Kaizer AM; Benson DW; Jaeggi E
    J Am Coll Cardiol; 2018 Oct; 72(16):1940-1951. PubMed ID: 30309472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
    Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
    Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies.
    Raboisson MJ; Fouron JC; Sonesson SE; Nyman M; Proulx F; Gamache S
    J Am Soc Echocardiogr; 2005 Apr; 18(4):375-80. PubMed ID: 15846168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to anti-Ro/SSA antibodies.
    Keller SB; Cohen J; Moon-Grady A; Cuneo B; Paul E; Coll AC; Campbell M; Srivastava S
    Ultrasound Obstet Gynecol; 2023 Jul; 62(1):148-151. PubMed ID: 36806323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA/Ro Pregnancies.
    Buyon JP; Masson M; Izmirly CG; Phoon C; Acherman R; Sinkovskaya E; Abuhamad A; Makhoul M; Satou G; Hogan W; Pinto N; Moon-Grady A; Howley L; Donofrio M; Krishnan A; Ahmadzia H; Levasseur S; Paul E; Owens S; Cumbermack K; Matta J; Joffe G; Lindblade C; Haxel C; Kohari K; Copel J; Strainic J; Doan T; Bermudez-Wagner K; Holloman C; Sheth SS; Killen S; Tacy T; Kaplinski M; Hornberger L; Carlucci PM; Izmirly P; Fraser N; Clancy RM; Cuneo BF
    Arthritis Rheumatol; 2024 Mar; 76(3):411-420. PubMed ID: 37947364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of complete heart block in a fetus and its perinatal management.
    Baxi L; Bierman F; Ursell P
    Am J Perinatol; 1987 Oct; 4(4):348-51. PubMed ID: 3307802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnancies.
    Gardiner HM; Belmar C; Pasquini L; Seale A; Thomas M; Dennes W; Taylor MJ; Kulinskaya E; Wimalasundera R
    Heart; 2007 Nov; 93(11):1454-60. PubMed ID: 17085531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal sonographic monitoring of progressive cardiac damages caused by anti-Ro antibodies: A case report.
    Tongprasert F; Sittiwangkul R; Lerthiranwong T; Tongsong T
    J Clin Ultrasound; 2018 Jun; 46(5):347-350. PubMed ID: 29023775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'.
    Scarsi M; Radice A; Pregnolato F; Ramoni V; Grava C; Bianchi L; Gerosa M; Mosca M; Ghirardello A; Tani C; Motta M; Quinzanini M; Tincani A; Ruffatti A; Migliorini P; Doria A; Meroni PL; Brucato A
    Clin Exp Rheumatol; 2014; 32(6):848-54. PubMed ID: 25327946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and frequency of fetal heart disease by echocardiography in pregnancies with high-risk factors].
    Hinojosa Cruz JC; Luis Miranda RS; Veloz Martínez MG; Puello Tamara E; Arias Monroy LG; Barra Urrutia A; Cetina Camara Ndel P; del Angel G; Gutiérrez González GA; Ramos García RA; Santos Vera I
    Ginecol Obstet Mex; 2006 Dec; 74(12):645-56. PubMed ID: 17539320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound findings in fetal congenital heart block associated with maternal anti-Ro/SSA and Anti-La/SSB antibodies.
    Lai J; Clark TJ; Tan JH; Delaney S; Jolley JA
    Ultrasound Q; 2015 Mar; 31(1):34-6. PubMed ID: 25706362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.
    Gerosa M; Cimaz R; Stramba-Badiale M; Goulene K; Meregalli E; Trespidi L; Acaia B; Cattaneo R; Tincani A; Motta M; Doria A; Zulian F; Milanesi O; Brucato A; Riboldi P; Meroni PL
    Rheumatology (Oxford); 2007 Aug; 46(8):1285-9. PubMed ID: 17449486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.